Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00902304 · ClinicalTrials.gov registry record · Phase 4
Valsartan Intensified Primary Care Reduction of Blood Pressure Study
A Phase 4 study, sponsored by Novartis Pharmaceuticals.
- Completed
- Registry status
- Phase 4
- Development phase
- 2,337
- Enrollment target
NCT00902304: Completed Phase 4 study, sponsored by Novartis Pharmaceuticals.
NCT00902304 is a Phase 4 study that has completed, run by Novartis Pharmaceuticals. The registered enrollment target is 2,337 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (351% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00902304, a Phase 4 study, has completed, sponsored by Novartis Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 2,337 participants
- Enrollment target
Study Summary
This study will assess the efficacy of an intensive blood pressure management strategy compared to usual care in a primary care (general practice) setting.
Primary Outcome
BP target groups were: \<= 125/75mmHg, \<= 130/80mmHg and \<= 140/90mmHg. The BP target was based on the patient's clinical risk profile as specified by National Heart Foundation of Australia guidelines.
Interventions
- DRUG Valsartan
- DRUG Usual care
- DRUG Valsartan and hydrochlorothiazide (HCTZ) - monotherapy
- DRUG Valsartan and amlodipine
- DRUG Valsartan and hydrochlorothiazide (HCTZ) - combination arm
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,337 participants |
| Start Date | 2009-07 |
| Est. Completion | 2011-07 |
| Phase | Phase 4 |
What the finished NCT00902304 record still lists
NCT00902304 is an interventional study that assigns participants to a tested intervention. Its 2,337 participants enrollment target places it among the larger protocols in the corpus, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (351% higher).
The record links to 0 conditions, and to 5 interventions - of which Valsartan is the first listed.
NCT00902304 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00902304 about?
NCT00902304 is a clinical study titled "Valsartan Intensified Primary Care Reduction of Blood Pressure Study". This study will assess the efficacy of an intensive blood pressure management strategy compared to usual care in a primary care (general practice) setting.
What is the current status of trial NCT00902304?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 2,337 participants. The study started on 2009-07. Estimated completion is 2011-07.
What interventions are being tested in trial NCT00902304?
The interventions under investigation include: Valsartan (DRUG), Usual care (DRUG), Valsartan and hydrochlorothiazide (HCTZ) - monotherapy (DRUG), Valsartan and amlodipine (DRUG), Valsartan and hydrochlorothiazide (HCTZ) - combination arm (DRUG).
Who is sponsoring clinical trial NCT00902304?
This trial is sponsored by Novartis Pharmaceuticals, which has 1,375 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00902304's enrollment target sits among peer trials
2,337 31st of 2000 higher than 1,970 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06679140 · 2,330 participants · Phase 3
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- NCT03099850 · 2,345 participants
Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies
- NCT00025935 · 2,350 participants
Studies of Brain Function and Course of Illness in Pediatric Bipolar Disorder
- NCT05700760 · 2,320 participants · NA
The ROSE Scale-up Study: Informing a Decision About ROSE as Universal PPD Prevention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia